|
Product complaint # (b)(4).Complainant part is expected to be returned for manufacturer review/investigation but has yet to be received.The investigation could not be completed, no product was received; no conclusion could be drawn at the time of filing this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H3, h6: a product investigation was conducted.Visual inspection: the dps haertoe cci std kit 1.25 k-wire/ -s (part #: 46.239.001, lot #: mhc200105) was received at us cq.Upon visual inspection, it was the insertion stick assembly (part # 46.239.210.10) that was received.The received device included the broken hammertoe cci implant (part # 46.239.101.10).One of the four legs/clamps of the hammertoe cci implant was broken off and was not returned; hence the complaint is confirmed.Dimensional inspection: no dimensional inspection was performed due to the post manufacturing damage.Document/specification review: relevant drawings were reviewed and no design issues or discrepancies were identified.Investigation conclusion: this complaint is confirmed as one of the leg/clamp of the hammertoe cci implant was broken off.No definitive root cause could be determined based on the provided information.No new, unique or different patient harms were identified as a result of this evaluation.There was no indication that a design or manufacturing issue contributed to the complaint.No design issues were observed during the document/specification review.Based on the investigation findings, it has been determined that no corrective and/or preventive action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post market safety surveillance activities.H3, h4, h6: a device history record (dhr) review was conducted: part # 46.239.001, synthes lot # mhc200105, supplier lot # mhc200105, release to warehouse date: 05 mar 2021 , supplier: (b)(4).No ncr's were generated during production.Review of the device history record(s) showed that there were no issues during the manufacture of this product, and any sub-components, which would contribute to this complaint condition.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|